Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication
For gastric protection or ulcer repair , oral administration may offer localized benefits, but should be approached cautiously due to variability in absorption
Often, yes
A 2025 IRB-approved pilot study published in PubMed reported no adverse effects following intravenous administration of 20mg in 2 healthy adults, with monitored biomarkers (heart, liver, kidneys, thyroid, and blood glucose) returning normal results
Now, there are a couple of things to understand about BPC-157, besides the fact that in animal studies, it's been shown to increase fibroblast migration to a site of injury, as well as endothelial cell and vascular growth to a site of injury
US$ 21.39
US$ 27.69
US$ 21.08
US$ 29.76
US$ 25.07
